Great Lakes Advisors LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 24.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,752 shares of the company's stock after selling 871 shares during the quarter. Great Lakes Advisors LLC's holdings in HCA Healthcare were worth $951,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock worth $8,796,000 after acquiring an additional 2,698 shares during the last quarter. Brown Advisory Inc. increased its stake in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after purchasing an additional 242 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in HCA Healthcare by 2.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after acquiring an additional 105 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in shares of HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after buying an additional 737 shares during the last quarter. Institutional investors own 62.73% of the company's stock.
Insider Activity
In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.30% of the company's stock.
HCA Healthcare Trading Up 2.2%
Shares of HCA Healthcare stock opened at $402.92 on Friday. The firm has a market capitalization of $94.28 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 1.24 and a beta of 1.41. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a 50 day moving average of $382.23 and a 200 day moving average of $362.27.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the prior year, the firm earned $5.50 earnings per share. The firm's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on HCA shares. Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a report on Wednesday. Barclays decreased their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Morgan Stanley cut their price target on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Finally, Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $403.17.
Get Our Latest Stock Analysis on HCA Healthcare
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.